PAD - Prescribing Advisory Database
Surrey
Prescribing Advisory Database

Guidelines : Generic prescribing

Detail

Condition :
Generic prescribing
Keywords :
Generics, INN, non-proprietary name, brand name, brand prescribing, prescribing by brand, branded generics, branded prescribing, brand to generics, proprietary name, recommended International Non-proprietary Name, rINN, Medicines Management
BNF Codes :

Committee Recommendations

Date
Committee Name
Narrative
Traffic Light Status
02 September 2020

The APC support the principle that, where generic medicines are available and there is no clinical rationale for the use of a particular brand, prescribers are requested to prescribe generically.

This principle is supported by a number of national and local resources:

In 2017 a list of the most frequently prescribed brands was presented to the APC where it was agreed that the brands would be assigned a black traffic light status. This list has not been updated but the prescribing of branded medicines is NOT supported. A list of exceptions and further information can be found here:

Generic vs Branded Prescribing Recommendations - Dec 2016 - updated Jan 2018

Please refer to this and the other resources below.

Patients already receiving branded medicines should be reviewed and switched to the generic alternative if there is no clinical rationale for the brand.

 
N/A

Documents

Supplementary documents (CCG specific documents)

No records returned.

Drugs

Below are listed drugs that are used to treat Generic prescribing.

  • No records returned.